oxyphenbutazone has been researched along with Facial Dermatoses in 2 studies
Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.
Facial Dermatoses: Skin diseases involving the FACE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cameli, N | 1 |
| Vincenzi, C | 1 |
| Morelli, R | 1 |
| Bardazzi, F | 1 |
| Tardio, M | 1 |
| Ikeda, T | 1 |
| Watanabe, S | 1 |
| Hayakawa, M | 1 |
2 other studies available for oxyphenbutazone and Facial Dermatoses
| Article | Year |
|---|---|
Contact allergy to oxyphenbutazone.
Topics: Dermatitis, Contact; Extremities; Facial Dermatoses; Female; Humans; Middle Aged; Oxyphenbutazone | 1991 |
[Granuloma faciale as an entity localized in the face--typical cases, cases affecting the limbs and the therapeutic effects of tanderil].
Topics: Arm; Diagnosis, Differential; Erythema; Facial Dermatoses; Female; Granuloma; Humans; Leg Dermatoses | 1968 |